Becton, Dickinson and Co. | BDX - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.06B 69M 2026-03
Agilent USD 7.36B 241M 2026-06
Align Technology USD 4.23B 83.03M 2026-06
AngioDynamics USD 176.33M 2.52M 2025-09
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Cooper Companies USD 8.36B 124.7M 2025-12
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 50.07B 1.09B 2026-03
Solventum Corp USD 4.8B 169M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 1.66T 77.51B 2026-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06